Insight Molecular Diagnostics Total Liabilities and Share Holders Equity 2014-2026 | IMDX
Insight Molecular Diagnostics total liabilities and share holders equity from 2014 to 2026. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
|
Insight Molecular Diagnostics Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2025 | $26 |
| 2024 | $35 |
| 2023 | $75 |
| 2022 | $100 |
| 2021 | $160 |
| 2020 | $55 |
| 2019 | $40 |
| 2018 | $10 |
| 2017 | $10 |
| 2016 | $14 |
| 2015 | $13 |
| 2014 | $5 |
| 2013 | $8 |
|
Insight Molecular Diagnostics Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2026-03-31 | $40 |
| 2025-12-31 | $26 |
| 2025-09-30 | $44 |
| 2025-06-30 | $51 |
| 2025-03-31 | $60 |
| 2024-12-31 | $35 |
| 2024-09-30 | $70 |
| 2024-06-30 | $75 |
| 2024-03-31 | $71 |
| 2023-12-31 | $75 |
| 2023-09-30 | $82 |
| 2023-06-30 | $88 |
| 2023-03-31 | $83 |
| 2022-12-31 | $100 |
| 2022-09-30 | $157 |
| 2022-06-30 | $171 |
| 2022-03-31 | $146 |
| 2021-12-31 | $160 |
| 2021-09-30 | $168 |
| 2021-06-30 | $177 |
| 2021-03-31 | $129 |
| 2020-12-31 | $55 |
| 2020-09-30 | $58 |
| 2020-06-30 | $63 |
| 2020-03-31 | $60 |
| 2019-12-31 | $40 |
| 2019-09-30 | $33 |
| 2019-06-30 | $38 |
| 2019-03-31 | $42 |
| 2018-12-31 | $10 |
| 2018-09-30 | $13 |
| 2018-06-30 | $12 |
| 2018-03-31 | $16 |
| 2017-12-31 | $10 |
| 2017-09-30 | $14 |
| 2017-06-30 | $12 |
| 2017-03-31 | $15 |
| 2016-12-31 | $14 |
| 2016-09-30 | $17 |
| 2016-06-30 | $7 |
| 2016-03-31 | $10 |
| 2015-12-31 | $13 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $6 |
| 2013-12-31 | $8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.102B | $0.004B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |